Real-time enrollment status for this drug resistant epilepsy clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 4:26 PM UTC
| NCT Number | NCT07145489 |
| Recruiting Status | Recruiting |
| Condition | Drug Resistant Epilepsy |
| Phase | Clinical Trial |
| Target Enrollment | 13 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Beth Israel Deaconess Medical Center |
| Last Updated on CT.gov | February 4, 2026 (Feb 4, 2026) |
As of July 13, 2026: Clinical trial NCT07145489 is currently recruiting participants. This clinical trial study for drug resistant epilepsy is actively seeking new participants at 1 location across the United States. The study is sponsored by Beth Israel Deaconess Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07145489 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07145489 was last updated Feb 4, 2026 (February 4, 2026). HelloStudys verifies this status automatically.